Board of Directors
Our Board of Directors drives our mission to innovate and lead in the medical device industry. Their diverse expertise in technology development and business leadership combined with their commitment to excellence guide our instrumental in our growth and success.
Meet our outstanding board of directors.
Caitlin Cameron
Caitlin Cameron, Chair, and CEO, Co-Founder. Ms. Cameron is a highly accomplished senior executive with 30 years of cross-industry expertise in the Life Sciences, Biotech, Technology, and IT industries. She is a specialist in building high-performing start-up companies. Previously, she held Chair and CEO positions at several Life Sciences and IT companies, building successful businesses and organizations, creating value, and maximizing potential in a very short period of time. In addition, she has built organizations known for employee satisfaction, including being selected for the 100 Best Places to Work in Washington. More
Mark Moehring, PhD
Mark Moehring, PhD, Co-founder and Chief Science Officer: Dr. Moehring is an industry-recognized leader in the field of medical ultrasound, with over three decades of experience in signal processing and medical ultrasound instrument design. His research and product development focus has been in the field of Doppler ultrasound, with a primary emphasis on diagnostic and therapeutic cranial and otitis media applications. Dr. Moehring is the inventor of 16 issued ultrasound and hemodynamic monitoring technology patents. More
Chris Rivera
Chris Rivera, Board Member: Mr. Rivera is a veteran life sciences executive with leadership experience at Tercica, Cephalon, Centocor, and Genzyme Therapeutics. He has expertise in building biotech companies, securing funding, FDA clearance, product launches, and achieving successful exits. He is Chairman, CEO, and President of EMulate Therapeutics and was founder and CEO of Hyperion Therapeutics, acquired by Horizon Pharma in 2015. From 2009 to 2015, he led Life Science Washington, mentoring over 400 startups and co-founding WINGS, Washington’s medical technology angel network. Mr. Rivera is known for his success in early-stage growth and biotech industry development. More
Andrea Gravatt, MD, FAAP, FAWN
ANDREA GRAVATT, MD, FAAP, FAWN, BOARD MEMBER: Dr. Gravatt has over four decades of experience in pediatric medicine and clinical education. A graduate of the University of Pittsburgh School of Medicine, she completed her Pediatric Internship and Residency at Duke University Medical Center. She has since served in high-impact clinical roles in pediatric emergency medicine. Dr. Gravatt joined the Seattle Children’s Hospital Emergency Department as an attending physician. Since 2002, she has been an Attending Physician in Pediatric Emergency Medicine at Mary Bridge Children’s Hospital. Dr. Gravatt is also a Clinical Professor of Pediatric Medicine at the University of Washington School of Medicine and Washington State University Elson S. Floyd College of Medicine. More
Brad Harlow
Brad Harlow, Board Member: Mr. Harlow is a seasoned executive and entrepreneur with a proven track record in healthcare technology, commercial lending, and strategic consulting. As President of CIDT Holdings, he drives shareholder value following the successful exit of Cardiac Insight, where he served as CEO for nearly a decade. He is also Chairman of Commerce Bridge Company, supporting small to mid-sized businesses with tailored financing solutions. Brad has held leadership roles at PhysioSonics and B. Harlow & Associates, and has advised companies such as Ventripoint, Guidant, and Spacelabs. His expertise spans strategy, operations, and finance, making him a trusted leader across multiple industries. MORE
Greg Sessler
Greg Sessler, board member: With a distinguished career spanning over three decades, Greg Sessler has served on the boards of six public and private life sciences and technology companies, holding key leadership roles, including Audit Chair and Compensation Committee member. He has successfully guided four companies through IPOs as CFO and played an instrumental role in several M&A transactions, including leading post-acquisition integration initiatives. Greg has held senior leadership roles at Olympus Surgical Technologies America, Olympus Respiratory America, Spiration, Rosetta Inpharmatics, SONUS Pharmaceuticals, and MicroProbe Corporation—companies that collectively achieved successful IPOs, acquisitions, and strategic partnerships. MORE